+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation



Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation



Supportive Care in Cancer 17(2): 145-151



Only a minimum is known about clinical effect of antimicrobial-coated central venous catheters (CVC) in stem cell transplantation settings, where CVC-related infections impose major threat to severely immunocompromised patients. In this prospective, non-sponsored and nonrandomized study, there were 49 uncoated multi-lumen and non-tunneled CVCs and 58 antimicrobial chlorhexidine/silver sulfadiazine-coated CVCs inserted in allogeneic stem cell transplanted patients to facilitate treatment during conditioning and pre-engraftment phase (<30days after transplantation). No significant differences were found between the two groups with respect to gender, age, intensity of pretransplant chemotherapy conditioning, duration of leucopenia, number of days with inserted CVC, number of CVC occlusive dressing changes performed per patient, and number of non-CVC-related infections. In the antimicrobial coated CVC group, there were observed less median days with fever [2 (0-18) vs. 4 (0-16), p = 0,17], fever incidence (67% vs. 77.5%, p = 0.28), and less days with fever per 1,000 catheter-days (108 vs. 147, p = 0.001), less patients with positive CVC blood cultures (36% vs. 45%, p = 0.05), repeatedly positive CVC blood cultures (8.6% vs. 26%, p = 0,018), less positive CVC blood cultures per 1,000 catheter-days (14 vs. 29, p = 0.005), and less positive CVC tip cultures (17.3% vs. 34.6%, p = 0.065) observed. Lower number of patients with fever, days with fever, and lower number of patients with positive and repeatedly positive CVC blood cultures indicates less intensive antibiotic and antipyretic treatment probably needed in neutropenic allo-transplanted patients with indwelling antimicrobial-coated CVCs. Real impact on antibiotic consumption should be verified in large randomized study.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051584771

Download citation: RISBibTeXText

PMID: 18449570

DOI: 10.1007/s00520-008-0454-9


Related references

The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation. European Journal of Cancer Care 18(5): 477-482, 2009

Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial. Supportive Care in Cancer 13(12): 993, 2005

Central venous catheters coated with chlorhexidine and silver sulfadiazine: our experience on a cardio-surgical population. European Journal of Anaesthesiology 23(Suppl. 38): 31-32, 2006

Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Medicine 30(4): 633-638, 2004

Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Archives of Internal Medicine 158(1): 81-87, 1998

Central venous catheters versus implantable intravenous devices in patients undergoing stem cell transplantation. Onkologie 23(Sonderheft 7): 172, 2000

Evaluation of a triple-lumen central venous catheter heparin-bonded versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients A randomized, clinical trial. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 426, 2001

Prevention of colonization of central venous catheters by silver-sulfadiazine-chlorhexidine bonding A pilot study in critical care patients. Anesthesiology 79(3A): A294, 1993

Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. Journal of Hospital Infection 37(2): 145-156, 1997

Effectiveness of Minocycline/Rifampin vs Chlorhexidine/Silver Sulfadiazine-Impregnated Central Venous Catheters. Journal of the American College of Surgeons 221(4): 891-892, 2015

Silver-coated central venous catheters reduce catheter-related infection compared with uncoated catheters, but do not affect the risk of thrombosis for people with cancer. Evidence-Based Oncology 3(3): 137-138, 2002

Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. Journal of Clinical Microbiology 34(10): 2640-2641, 1996

Effect of chlorhexidine/silver sulfadiazine coating on microbial colonization of central venous catheters in a multicenter trial. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 439, 2001

Inhibitory effect of explanted chlorhexidine-silver sulfadiazine impregnated central venous catheters on Staphylococcus epidermidis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 422, 2000

Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion. New Microbiologica 35(2): 175-182, 2012